Education
About Us
Working with TipRanks
Follow Us
Biophytis Sa (BPTSY)
OTHER OTC:BPTSY
BPTSY Stock Chart & Stats
$1.60
-$1.35(-31.02%)
At close: 4:00 PM EST
$1.60
-$1.35(-31.02%)
Day’s Range― - ―
52-Week Range$0.81 - $4.42
Previous CloseN/A
Volume804.00
Average Volume (3M)52.00
Market Cap
$3.31M
Enterprise Value$10.37M
Total Cash (Recent Filing)$1.42M
Total Debt (Recent Filing)$9.12M
Price to Earnings (P/E)―
Beta0.21
Next Earnings
Feb 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.96
Shares Outstanding3,955,662
10 Day Avg. Volume88
30 Day Avg. Volume52
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-1.60
Price to Sales (P/S)0.00
P/FCF Ratio-1.79
Enterprise Value/Market Cap3.13
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-45.85
Enterprise Value/Ebitda-1.46
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-3.86
Revenue Forecast (FY)$1.76M
Biophytis News
BPTSY FAQ
What was Biophytis Sa’s price range in the past 12 months?
Biophytis Sa lowest stock price was $0.81 and its highest was $4.42 in the past 12 months.
What is Biophytis Sa’s market cap?
Biophytis Sa’s market cap is $3.31M.
When is Biophytis Sa’s upcoming earnings report date?
Biophytis Sa’s upcoming earnings report date is Feb 23, 2026 which is in 55 days.
How were Biophytis Sa’s earnings last quarter?
Biophytis Sa released its earnings results on Nov 04, 2025. The company reported -$1.962 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.962.
Is Biophytis Sa overvalued?
According to Wall Street analysts Biophytis Sa’s price is currently Overvalued.
Does Biophytis Sa pay dividends?
Biophytis Sa does not currently pay dividends.
What is Biophytis Sa’s EPS estimate?
Biophytis Sa’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biophytis Sa have?
Biophytis Sa has 3,955,662 shares outstanding.
What happened to Biophytis Sa’s price movement after its last earnings report?
Biophytis Sa reported an EPS of -$1.962 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.55%.
Which hedge fund is a major shareholder of Biophytis Sa?
Currently, no hedge funds are holding shares in BPTSY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Biophytis Sa
Biophytis (BPTSY) is a clinical-stage biotechnology company focused on the development of therapeutics aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases. The company's product pipeline includes drug candidates targeting neuromuscular diseases such as sarcopenia and other conditions like severe respiratory failure in COVID-19 patients. Biophytis utilizes its proprietary technology platforms to advance its research and development efforts in these areas.
Technical Analysis
Oragenics
―
InMed Pharmaceuticals
―
Pasithea Therapeutics Corp
―
SciSparc Ltd.
―
Onconetix
―